ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective.

Koessler, T.; Alsina, M.; Arnold, D.; Ben-Aharon, I.; Collienne, M.; Lutz, M.P.; Neuzillet, C.; Obermannova, R.; Peeters, M.; Sclafani, F.; Smyth, E.; Valle, J.W.; Wagner, A.D.; Wyrwicz, L.; Fontana, E.; Moehler, M.

doi:10.1016/j.esmoop.2022.100392

ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective.

Détails

Télécharger: 35180656_BIB_851DF44B5BE1.pdf (324.20 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0

ID Serval

serval:BIB_851DF44B5BE1

Type

Article: article d'un périodique ou d'un magazine.

Sous-type

Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.

Collection

Publications

Institution

UNIL/CHUV

Titre

ESMO Congress 2021: highlights from the EORTC gastrointestinal tract cancer group's perspective.

Périodique

ESMO open

Auteur⸱e⸱s

Koessler T., Alsina M., Arnold D., Ben-Aharon I., Collienne M., Lutz M.P., Neuzillet C., Obermannova R., Peeters M., Sclafani F., Smyth E., Valle J.W., Wagner A.D., Wyrwicz L., Fontana E., Moehler M.

ISSN

2059-7029 (Electronic)

ISSN-L

2059-7029

Statut éditorial

Publié

Date de publication

04/2022

Peer-reviewed

Oui

Volume

Numéro

Pages

100392

Langue

anglais

Notes

Publication types: Congress ; Journal Article ; Review ; Research Support, Non-U.S. Gov't
Publication Status: ppublish

Résumé

There has been no major change of practice in gastrointestinal oncology at the European Society for Medical Oncology (ESMO) symposium 2021, but confirmation that immunotherapy in combination with chemotherapy has become standard of care in several indications. The European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Track Cancer Group has selected important phase II and III trials presented during the symposium across all gastrointestinal cancers as well as early reports on new drugs or new combinations that may change practice in the future.

Mots-clé

Gastrointestinal Neoplasms/drug therapy, Humans, Immunotherapy, Medical Oncology, colorectal cancer, neuroendocrine tumours, oesophagus cancer, pancreatic cancer, stomach cancer

URN

urn:nbn:ch:serval-BIB_851DF44B5BE15

OAI-PMH

oai:serval.unil.ch:BIB_851DF44B5BE1

DOI

10.1016/j.esmoop.2022.100392

Pubmed

35180656

Web of science

000819921700001

Open Access

Oui